Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone vs. Endocrine Therapy Alone or Combined Treatment for Low-Risk ER-positive Early-Stage Breast Cancer in Women Age 65 and Older.

International journal of radiation oncology, biology, physics(2022)

Cited 1|Views19
No score
Abstract
U-WBI alone appears the more cost-effective de-escalation strategy for these patients, compared to AI alone. Combining U-WBI and AI appears more costly but may be preferred by some patients.
More
Translated text
Key words
breast cancer,cost,cost-effectiveness,endocrine therapy,radiation therapy,toxicity,utility
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined